Subtype
Early Stage Breast Carcinoma
CI-CAN-00002563Explore in graph →
57 active trials2 approved drugs
- NCIt
- C94774
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002563Explore in graph →
Clinical trials
145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (13)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05345860 | Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer(AMENDER) | recruiting | N/A | 300 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT05280288 | Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer | unknown | N/A | 120 | Rigshospitalet, DenmarkOTHER | 0 | Mar 15, 2022 |
| clinicaltrials |
| NCT03894007 | Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer(PREDIXIIHER2) | terminated | Phase 2 | 6 | Renske AltenaOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT02603679 | Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases(PREDIX LumB) | active not recruiting | Phase 2 | 181 | Thomas HatschekOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT03946683 | Cyberknife for Early Stage Breast Cancer | completed | N/A | 26 | NYU Langone HealthOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03102307 | Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD) | completed | — | 548 | Kliniken Essen-MitteOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT03618017 | The ConnectedCancerCare Pilot Study (CCC)(CCC) | completed | N/A | 66 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04607473 | ABUS for Early-stage Breast Cancer | unknown | N/A | 675 | Samsung Medical CenterOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00309491 | Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients | completed | Phase 3 | 2,021 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 0 | Oct 19, 2020 | clinicaltrials |
| NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | completed | Phase 3 | 429 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 0 | Oct 14, 2020 | clinicaltrials |
| NCT02485678 | A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer(AToM) | completed | N/A | 1,460 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT03651921 | Testing of the Cancer Thriving and Surviving Breast Cancer Program(COSS) | completed | N/A | 39 | Manuela EicherOTHER | 1 | Aug 24, 2020 | clinicaltrials |
| NCT02159157 | A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast Cancer | completed | N/A | 28 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT01162200 | Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer | completed | Phase 1 | 75 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT02568839 | Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer(PREDIX HER2) | active not recruiting | Phase 2 / Phase 3 | 202 | Thomas HatschekOTHER | 1 | Aug 13, 2020 | clinicaltrials |
| NCT02481128 | Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer | completed | N/A | 1,198 | Kliniken Essen-MitteOTHER | 2 | Jul 9, 2020 | clinicaltrials |
| NCT02592083 | Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors(PREDIX LumA) | active not recruiting | Phase 2 | 10 | Thomas HatschekOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT02441946 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer(neoMONARCH) | completed | Phase 2 | 224 | Eli Lilly and CompanyINDUSTRY | 10 | Jun 17, 2020 | clinicaltrials |
| NCT02816112 | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia(REaCT-TC2) | completed | Phase 4 | 458 | Ottawa Hospital Research InstituteOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT01545648 | Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer | terminated | Phase 2 | 4 | Hope Rugo, MDOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT02947425 | TARGeted Intraoperative radioTherapy (TARGIT) Registry Database(TARGIT R) | unknown | — | 2,000 | University College, LondonOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT03797248 | Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer | unknown | — | 310 | Chang Gung Memorial HospitalOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT04003558 | Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01) | unknown | — | 1,500 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT02806817 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | completed | Early Phase 1 | 40 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03886389 | Breast Cancer Diet Intervention Study(BCDIS) | completed | N/A | 80 | Helse Stavanger HFOTHER_GOV | 0 | May 13, 2019 | clinicaltrials |
| NCT02511301 | Circadian Thermal Sensing to Detect Breast Disease | unknown | Phase 1 / Phase 2 | 173 | Cyrcadia HealthINDUSTRY | 1 | Jan 3, 2019 | clinicaltrials |
| NCT02364960 | Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)(TARGIT) | terminated | — | 16 | TriHealth Inc.OTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT02095743 | Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer(EPIC) | unknown | Phase 2 | 256 | Centre Henri BecquerelOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT03468374 | Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT | unknown | N/A | 4 | Assiut UniversityOTHER | 0 | Mar 16, 2018 | clinicaltrials |
| NCT01871116 | POWER-remote Weight Loss Program in Early Stage Breast Cancer | completed | N/A | 96 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT03003611 | Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer | completed | — | 150 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01965522 | Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer(MELO-D) | completed | Phase 2 | 100 | Juravinski Cancer CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT00165243 | Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer | completed | Phase 2 | 100 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT02310984 | PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional(PICTURE XS) | completed | — | 222 | University College, LondonOTHER | 3 | Mar 17, 2017 | clinicaltrials |
| NCT02982148 | Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients | unknown | Phase 4 | 352 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02958033 | Shandong Cancer Hospital Affiliated to Shandong University | unknown | Phase 3 | 100 | Shandong Cancer Hospital and InstituteOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT00665899 | A Couples Approach to Enhance Breast Cancer Survivorship(CanThrive) | completed | N/A | 163 | University of North Carolina, Chapel HillOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT00636441 | Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer | terminated | Phase 2 | 56 | Duke UniversityOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT01166581 | Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates | terminated | — | 300 | Summa Health SystemOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT00233077 | Patient Centered Randomized Controlled Trial | completed | N/A | 374 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01157130 | Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory | unknown | N/A | 100 | Nevada Cancer InstituteOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00671385 | Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning | unknown | — | 2,000 | Spectros CorporationINDUSTRY | 1 | Feb 1, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Apr 26, 2022source: clinicaltrials